Detalles de la búsqueda
1.
Vimentin expression correlates with immune checkpoint inhibitor efficacy in non-small cell lung cancer.
Cancer;
129(15): 2297-2307, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021822
2.
Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non-small cell lung cancer.
Cancer Sci;
113(9): 3148-3160, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722982
3.
Phase 1b study of ramucirumab in combination with erlotinib or osimertinib for untreated EGFR-mutated non-small cell lung cancer patients with asymptomatic brain metastases.
Invest New Drugs;
39(6): 1598-1603, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34215931
4.
Early-onset meningitis associated with atezolizumab treatment for non-small cell lung cancer: case report and literature review.
Invest New Drugs;
38(6): 1901-1905, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32399862
5.
Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancer.
Cancer Sci;
110(10): 3244-3254, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31368625
6.
Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer.
Cancer Chemother Pharmacol;
92(5): 381-390, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606723
7.
Influence of Smoking History on the Effectiveness of Immune-checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer: Analysis of Real-world Data.
Anticancer Res;
43(5): 2185-2197, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097681
8.
RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression.
Anticancer Res;
43(10): 4663-4672, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772582
9.
A case of PD-L1 negative advanced pulmonary sarcomatoid carcinoma effectively treated with atezolizumab, carboplatin, paclitaxel, and bevacizumab.
Respir Med Case Rep;
36: 101579, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35059287
10.
Association of thyroid transcription factor-1 with the efficacy of immune-checkpoint inhibitors in patients with advanced lung adenocarcinoma.
Thorac Cancer;
13(16): 2309-2317, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35808895
11.
SP142 evaluation contributes to the prediction of immune checkpoint inhibitor efficacy in non-small cell lung cancer with high PD-L1 expression assessed by 22C3.
Transl Lung Cancer Res;
11(12): 2438-2451, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636414
12.
Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors.
Sci Rep;
11(1): 5680, 2021 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33707471
13.
Tumor microenvironment disparity in multiple primary lung cancers: Impact of non-intrinsic factors, histological subtypes, and genetic aberrations.
Transl Oncol;
14(7): 101102, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33930847
14.
Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan.
BMJ Open;
10(9): e035615, 2020 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32907893
15.
Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian).
J Thorac Dis;
12(7): 3776-3784, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32802457
Resultados
1 -
15
de 15
1
Próxima >
>>